Archive

Dive into a collection of past posts and rediscover timeless content.

The Skill That Matters More Than Expertise: What a Pharma VP Learned in 25 Years

A Conversation with Peter Wickersham, Vice President & General Manager of a Major UK Pharma Affiliate

Feb 17, 2026

•

9 min read

The UK's Innovation Dilemma: Is Britain Pricing Itself Out of the Medicine Market?

The UK spends significantly less of its health budget on branded medicines than comparable nations. Termination rates in the appraisal process have doubled. And companies are increasingly choosing not to launch here at all. A conversation with the ABPI's Jack Neill-Hall about what's at stake—and where the opportunity lies.

Feb 16, 2026

•

6 min read

The Patient Voice is Still Underused

Bridging the Gap Between Endpoints, HTA, and Lived Experience

Feb 9, 2026

•

4 min read

Why Karl Claxton Warned Against the NICE Threshold Change (And Why It Happened Anyway)

The Warning That Went Unheeded

Feb 8, 2026

•

7 min read

Responsibility, Risk, and the Future of Evidence

What building a HEOR consultancy during COVID reveals about leadership, judgment, and where our field is heading

Feb 7, 2026

•